RxDoctor Payments DataLook up a doctor →

Priyanka Gupta, MD

Allergy/ Immunology · New Braunfels, TXNPI 1346281839

Payments from drug & device makers

$207,301in general payments, 2019–2025

Across 674 payments — averaging $307.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$150K
  • Optinose US, Inc.$49K
  • GSK$1K
  • CSL Behring$669
  • Kaleo, Inc.$558
  • Regeneron Healthcare Solutions, Inc.$514
  • plus $5K from 39 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca244$150,196
Optinose US, Inc.123$49,351
GSK74$1,058
CSL Behring36$669
Kaleo, Inc.20$558
Regeneron Healthcare Solutions, Inc.20$514
Takeda Pharmaceuticals U.S.A., Inc.20$495
Alk-abello, Inc9$435
Amgen14$312
Novartis9$302
Sanofi9$301
Grifols USA, LLC13$247
Genentech USA, Inc.10$230
ARS Pharmaceuticals Operations, Inc.5$213
Teva Pharmaceuticals USA, Inc.4$201
Jubilant Hollisterstier LLC1$200
Aimmune Therapeutics, Inc.2$191
Pfizer9$160
Galderma Laboratories, L.p.2$141
Incyte Corporation5$126
Biohaven Pharmaceutical Holding Company Ltd.1$125
Abbott1$123
Blueprint Medicines Corporation1$121
Sanofi-aventis U.S. LLC5$109
Cardiovascular Systems Inc.1$104
Hikma Pharmaceuticals USA4$88
Medtronic1$85
Pharming Healthcare, Inc.4$81
Octapharma USA, Inc.4$80
Biocryst US Sales Co., LLC3$59
Ionis Pharmaceuticals, Inc.2$50
Boehringer Ingelheim2$47
Mylan Pharmaceuticals Inc.2$42
Greer Laboratories, Inc.1$41
Organon2$37
Shire North American Group Inc2$35
Bio Products Laboratory USA, Inc.1$27
Lilly USA, LLC1$25
Paratek Pharmaceuticals, Inc.1$21
Biocryst Pharmaceuticals, Inc.1$20
Almirall LLC1$18
Philips North America LLC1$18
Bausch & Lomb, A Division Of Bausch Health US, LLC1$16
Circassia Inc.1$16
Aytu Biopharma, Inc.1$12

How this compares

Too few allergy/ immunology providers in Texasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,056,711
Medicare patients
617
Services billed
39,174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy/ immunology in New Braunfels

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →